Cargando…
Mutual exclusivity of ESR1 and TP53 mutations in endocrine resistant metastatic breast cancer
Both TP53 and ESR1 mutations occur frequently in estrogen receptor positive (ER+) metastatic breast cancers (MBC) and their distinct roles in breast cancer tumorigenesis and progression are well appreciated. Recent clinical studies discovered mutual exclusivity between TP53 and ESR1 mutations in met...
Autores principales: | Li, Zheqi, Spoelstra, Nicole S., Sikora, Matthew J., Sams, Sharon B., Elias, Anthony, Richer, Jennifer K., Lee, Adrian V., Oesterreich, Steffi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090919/ https://www.ncbi.nlm.nih.gov/pubmed/35538119 http://dx.doi.org/10.1038/s41523-022-00426-w |
Ejemplares similares
-
Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance
por: Martin, Lesley-Ann, et al.
Publicado: (2017) -
Detection of ESR1 mutations in circulating cell-free DNA from patients with metastatic breast cancer treated with palbociclib and letrozole
por: Gyanchandani, Rekha, et al.
Publicado: (2016) -
Mutation site and context dependent effects of ESR1 mutation in genome-edited breast cancer cell models
por: Bahreini, Amir, et al.
Publicado: (2017) -
ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation
por: Li, Zheqi, et al.
Publicado: (2022) -
Algorithms for mutual exclusion /
por: Raynal, Michel
Publicado: (1986)